Why is this joint guide here?

What can a study tell me about my joint?

A human study can tell you what happened to the people who took part. It can't promise that your joint will react the same way. Results from sore knees may not apply to a shoulder or hip.

Animal research can help explain how cells might act, but an animal isn't a person. A doctor still needs to examine you, review your medicines, and hear what has changed.

Studies guide a choice; they don't make it for you.

A hot swollen joint, major injury, or new weakness needs medical care. More reading can't rule out an urgent cause.

Who is behind this guide?

Mesa Joint Field Notes is operated by the owners of the QC Kinetix Phoenix-area clinics. The business benefits when a reader books a consultation through this site.

What does that mean for my visit?

Name the movement that hurts and the task you want back. Bring questions, your medicine list, and past X-rays or visit notes. Ask what the treatment involves, how long relief may last, and what the studies haven't shown.

You can take time before saying yes.

A useful visit may end with different home care or a referral elsewhere. It shouldn't turn doubt into a promise. At QC Kinetix, a medical provider can examine you and discuss regenerative treatments, non-surgical care prepared from your blood and placed near the sore area.

Sources

1. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programmes, tai chi, cane use, hand orthoses for first-CMC joint OA, tibiofemoral bracing, topical NSAIDs for the knee, oral NSAIDs and intra-articular glucocorticoid injections for the knee; acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol are only conditional.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

2. In the 454-person IDEA randomized trial, 18 months of intensive diet plus exercise produced 10.6 kg (11.4%) mean weight loss and less pain and better function than either diet alone or exercise alone in overweight and obese adults aged 55 and older with painful radiographic knee OA. The exercise-only group lost 1.8 kg (2.0%).

   Messier SP, et al. — Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial.. JAMA, 2013. DOI: 10.1001/jama.2013.277669.

3. In a 68-week double-blind placebo-controlled trial of 407 participants with obesity and moderate knee osteoarthritis, once-weekly semaglutide 2.4 mg produced -13.7% body weight change versus -3.2% with placebo, and a WOMAC pain change of -41.7 points versus -27.5 with placebo (P<0.001 for both), with a greater SF-36 physical-function gain.

   Bliddal H, et al. — Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.. N Engl J Med, 2024. DOI: 10.1056/NEJMoa2403664.

4. The RESTORE randomized clinical trial (n=288) compared three weekly intra-articular injections of leukocyte-poor PRP with saline placebo in symptomatic mild-to-moderate medial knee OA. At 12 months the mean change in knee pain was -2.1 versus -1.8 points (difference -0.4, 95% CI -0.9 to 0.2, P=.17) and the mean change in medial tibial cartilage volume was -1.4% versus -1.2% (P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.